Immunology and Genetic Mechanisms in Liver Transplantation
Liver transplantation is a life-saving procedure for patients with end-stage liver diseases, but its success depends heavily on managing immune responses and understanding genetic factors. Immunology plays a central role in both the rejection of transplanted livers and the long-term survival of transplant recipients. The body's immune system recognizes the donor liver as foreign and may initiate an immune response, leading to acute or chronic rejection. This requires careful immunosuppressive therapy to prevent rejection while managing the risks of infection and malignancy.
Genetic factors, both in the donor and recipient, influence transplant outcomes. Genetic incompatibility between donor and recipient, particularly with human leukocyte antigens (HLA), can affect the likelihood of rejection. Research into genomic profiling is helping to identify patients at higher risk for rejection or graft failure, allowing for more personalized treatment strategies.
This track will delve into the latest advancements in the immunology and genetic mechanisms influencing liver transplantation, offering insights into improving graft survival, minimizing rejection, and advancing personalized care for transplant patients.
Related Conference of Immunology and Genetic Mechanisms in Liver Transplantation
24th International Conference on Gastroenterology and Digestive Disorders
26th International Conference on Gastroenterology and Hepatology
20th World Congress on Gastroenterology -Therapeutics & Hepatology
17th International Conference on Liver Diseases & Hepatology
Immunology and Genetic Mechanisms in Liver Transplantation Conference Speakers
Recommended Sessions
- Advanced Liver Regeneration and Stem Cell Research
- Advanced Techniques in Gastrointestinal Imaging
- Advancements in Non-invasive Liver Diagnostic
- Advances in Endoscopic Techniques and Innovations
- Advances in Gut-Associated Lymphoid Tissue (GALT) and Immunity
- Advances in Pancreatitis Treatment: Managing Acute and Chronic Cases
- AI in Early Diagnosis of Colorectal Cancer
- Chronic liver disease management
- Colorectal Cancer: Early Detection, Diagnosis, and Therapeutics
- CRISPR-Cas9 in Gastrointestinal and Hepatic Disease Research
- Genetic and Immunological Mechanisms in Autoimmune Gastrointestinal Disorders
- Genetic Markers for Predicting Inflammatory Responses in Liver Disease
- Genetic Pathways in Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH
- Gut-Brain Connection in Gastroenterology
- Hepatitis D: The Silent Epidemic in Hepatology
- Hepatitis E: Latest Updates and Research
- Hepatocellular Carcinoma (HCC): Early Detection and Management
- Immunology and Genetic Mechanisms in Liver Transplantation
- Immunotherapy in GI Cancer Treatment
- Microbiome and Gut Health
- Microbiome and Its Impact on Colorectal Cancer (CRC)
- Obesity and Bariatric Surgery
- Pediatric Gastroenterology and Hepatology
- Precision medicine in gastroenterology
- Role of Artificial Intelligence in Clinical Decision Making
- Role of MicroRNAs in Genetic Regulation of Liver Diseases
- Targeting Genetic Pathways in Gastrointestinal Inflammation
- Translational Research in Gastroenterology and Hepatology
Related Journals
Are you interested in
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Gastrointestinal Therapeutics - Gastroenterology – 2025 (France)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Liver Transplantation - Gastroenterology-2025 (UAE)
- Advances in Pancreatic Disease Management - Gastroenterology-2025 (UAE)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Artificial Intelligence in Gastroenterology - Gastroenterology-2025 (UAE)
- Bariatric Endoscopy & Obesity Management - Gastroenterology-2025 (UAE)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease and Gluten-Related Disorders - Gastroenterology – 2025 (France)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Cirrhosis & Portal Hypertension Management - Gastroenterology-2025 (UAE)
- Colorectal Cancer: Prevention, Screening, and Treatment - Gastroenterology – 2025 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Early Detection of Gastrointestinal Cancers - Gastroenterology-2025 (UAE)
- Emerging Biomarkers in Gastroenterology - Gastroenterology-2025 (UAE)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Emerging Therapies for Inflammatory Bowel Disease - Gastroenterology-2025 (UAE)
- Endoscopic Innovations and Techniques - Gastroenterology – 2025 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- FMT & Microbiota-Based Therapies - Gastroenterology-2025 (UAE)
- Functional GI Disorders & Motility Diseases - Gastroenterology-2025 (UAE)
- Functional GI Disorders: IBS and Beyond - Gastroenterology – 2025 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Antimicrobial Resistance - Gastroenterology – 2025 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology: From Screening to Targeted Therapies - Gastroenterology – 2025 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- GI Bleeding & Emergency Endoscopy - Gastroenterology-2025 (UAE)
- GI Oncology: Colorectal and Pancreatic Cancers - Gastroenterology – 2025 (France)
- Gut Microbiome in GI Diseases - Gastroenterology-2025 (UAE)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Immunotherapy in GI Cancers - Gastroenterology-2025 (UAE)
- Inflammatory Bowel Disease (IBD): Crohn’s and Ulcerative Colitis - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease (IBD): Insights and Advancements - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Innovations in Endoscopy - Gastroenterology-2025 (UAE)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Cirrhosis and Complications - Gastroenterology – 2025 (France)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastroenterology – 2025 (France)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Microbiome and Gut Health - Gastroenterology – 2025 (France)
- NAFLD & NASH Management - Gastroenterology-2025 (UAE)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH - Gastroenterology – 2025 (France)
- Nutrition & Liver Health - Gastroenterology-2025 (UAE)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology Breakthroughs - Gastroenterology-2025 (UAE)
- Pediatric Gastroenterology: Challenges and Innovations - Gastroenterology – 2025 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer Disease and H. pylori Infection - Gastroenterology – 2025 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Post-COVID GI Complications - Gastroenterology-2025 (UAE)
- Precision Medicine in Hepatology - Gastroenterology-2025 (UAE)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis Treatment Innovations - Gastroenterology-2025 (UAE)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)